Sunday, July 21, 2024
HomeCancerVaccine Therapy For Prostate Cancer

Vaccine Therapy For Prostate Cancer

Is This The First Mrna Vaccine Against Cancer

Cancer Vaccines: Jump Starting an Immune Response to Cancer

No, far from it. Researchers have been using the mRNA approach to try to treat cancer since at least 2008. The results have been mixed, but the technology is improving and the success of the mRNA covid-19 vaccines has given the field a big boost. As yet, no mRNA-based cancer vaccine has been approved, but many trials are currently under way or planned.

Questions To Ask Your Health Care Team

If you want to learn more about joining a cancer treatment vaccine clinical trial, talk with your health care team. You may want to ask these questions:

  • Is there a clinical trial testing a vaccine for my type and stage of cancer?

  • Where is the clinical trial located?

  • What is the vaccine and how does it work?

  • How is the vaccine made? Will I need blood cells or tumor tissue removed to make the vaccine? How will you remove it?

  • How will I receive the vaccine and how often?

  • How long will I need the vaccine?

  • What side effects could occur?

  • Can I receive the vaccine with other treatments such as radiation therapy or chemotherapy?

  • What are the other treatment options for this cancer?

How Does The Immune System Work

The immune system helps keep our bodies healthy. It attacks foreign invaders. The immune system fights against things like bacteria, viruses, parasites, and fungus that can enter your body. The immune system also fights against cells already in the body that have changed due to illness, like when there is cancer in the body. The immune system is made up of organs, cells, and proteins.

White blood cells, also called leukocytes, look for these foreign invaders and destroy them. There are two types of leukocytes:

  • B lymphocytes: Find the pathogens. B lymphocytes also make antibodies. Antibodies are proteins in the body that fight infections that your body has already been exposed to.
  • T lymphocytes: Destroy the pathogens.

Read Also: Prostate Cancer In Older Men

Advancing The Science Of Mrna Cancer Vaccines

A lot of immunotherapies stimulate the immune response in a nonspecific waythat is, not directly against the cancer, said Dr. Ott. Personalized cancer vaccines can direct the immune response to exactly where it needs to be.

Some companies are also investigating mRNA cancer vaccines that are based on collections of a few dozen neoantigens that have been linked with certain types of cancer, including prostate cancer, gastrointestinal cancers, and melanoma.

In addition to clinical trials, fundamental research on mRNA cancer vaccines continues. Some investigators are trying to enhance the responses of immune cells to neoantigens in mRNA vaccines. One study, for example, aims to improve the responses of T cells that become exhausted while attacking tumors.

A challenge for the field is learning how best to identify neoantigens for personalized mRNA cancer vaccines, several researchers said.

Theres still a lot we need to learn and many questions to answer, Dr. Ott said. Its not yet clear, for example, how personalized cancer vaccines should be best combined with other treatments, such as immune checkpoint inhibitors, he added.

As cancer researchers pursue these questions, other investigators will be developing knowledge from the growing number of people around the world who are receiving mRNA coronavirus vaccines.

Does This Mean The Vaccine Could Help Up To Half Of Those Diagnosed With Pancreatic Cancer

Prostate Cancer Vaccine Found Not To Improve Survival

Unfortunately not. Firstly, this is a very small initial trial. Larger and longer trials will be needed to confirm the result. Secondly, the trial only involved people whose cancers were detected early enough that they could undergo an operation to remove tumours before they spread to other parts of the body. Only around 10 per cent of people are diagnosed at this stage, says Chris Macdonald, head of research at charity Pancreatic Cancer UK. In other words, even if larger trials confirm these initial results, it remains to be seen if this vaccine can help people with more advanced pancreatic cancer though that is, of course, the hope.

Don’t Miss: How Do They Stage Prostate Cancer

Trial Objectives And Outline


I. To evaluate the safety of serial intradermal vaccinations of a deoxyribonucleic acid vaccine encoding androgen receptor ligand-binding domain , with or without GM-CSF as an adjuvant, in patients with metastatic prostate cancer.

II. To evaluate whether AR LBD-specific interferon gamma-secreting cluster of differentiation 8+ T cells and antigen-specific memory CD8+ T-cells can be elicited in patients by vaccination.


I. To evaluate different schedules of vaccine administration best able to elicit long-lived AR LBD-specific T-cell responses.

II. To evaluate the effect of GM-CSF as an adjuvant to elicit persistent AR LBD-specific T-cell responses.

III. To determine the median time to prostate-specific antigen progression and 18-month PSA-progression-free survival of treated patients.

OUTLINE: Patients are randomized to 1 of 4 arms.

ARM I: Patients receive androgen receptor ligand-binding domain-encoding plasmid DNA vaccine MVI-118 intradermally at 0, 2, 4, 6, 8, 10, 12, 24, 36, and 48 weeks.

ARM II: Patients receive androgen receptor ligand-binding domain-encoding plasmid DNA vaccine MVI-118 ID at 0, 2, 12, 14, 24, 26, 36, 38, 48, and 50 weeks.

ARM III: Patients receive androgen receptor ligand-binding domain-encoding plasmid DNA vaccine MVI-118 as in Arm I and sargramostim ID at 0, 2, 4, 6, 8, 10, 12, 24, 36, and 48 weeks.

What Is A Cancer Vaccine

Most of us have gotten vaccines for infectious diseases, like measles and hepatitis. These vaccines use weak or dead forms of viruses, bacteria, or other germs to start an immune response in the body. Cancer vaccines teach the immune system to find, attack and destroy cancer cells.

When foreign cells enter the body , the immune system responds and clears the body of the foreign cells. However, cancer cells are not seen as foreign by the body. The immune system thinks the cancer cells are part of the normal body and do not start an immune response against the cancer. Cancer vaccines help the immune system recognize cancer cells as foreign. Your immune system can then attack the cancer cells. Cancer vaccines are one way to use the bodys immune system to fight cancer.

Don’t Miss: Metastatic Prostate Cancer Castration Resistant

Prostatespecific Tumorassociated Antigens As Targets For Immunotherapy

The ideal targets for vaccinemediated immune responses are TAAs that are overexpressed in, or unique to, cancer cells relative to nonmalignant tissue. Prostate cancer cells express several of these TAAs. PSA is a 34kD protein uniquely expressed in prostate cancer cells and in nonessential epithelial cells within the prostate, making it the main target for numerous prostate cancer vaccines.4, 5 Prostatespecific membrane antigen is a 100kD transmembrane glycoprotein mainly expressed in primary and metastatic prostate cancer cells.6 This TAA is unique in that its expression is augmented by androgen deprivation, a fundamental treatment for prostate cancer.7 Another potential target for vaccines is prostatic acid phosphatase , a 102kD TAA glycoprotein expressed on over 95% of prostate cancer cells and believed to be associated with disease progression.8, 9

A Trial Of A Vaccine Called Prostvac For Prostate Cancer

Prostate Cancer and Immunotherapy with Dr. Ana Aparicio

Please note – this trial is no longer recruiting patients. We hope to add results when they are available.

Cancer type:


This trial is looking at a new vaccine called PROSTVAC for prostate cancer that has spread.

If prostate cancer has spread outside the prostate gland, doctors often treat it with hormone therapy. This can work very well, but at some stage the cancer may start to grow again. This may not cause symptoms, but your doctor might see changes on a scan or there may be an increase in the level of PSA in your blood.

The immune system can recognise and kill cancer cells. But it is not always very good at doing this. In this trial, researchers are looking at a vaccine called PROSTVAC that can help the immune system to recognise and attack prostate cancer cells.

GM-CSF is a type of growth factor. Growth factors are proteins made in the body and some of them make the bone marrow produce blood cells. GM-CSF makes the body produce white blood cells. The researchers want to find out if giving GM-CSF alongside the vaccine can help it to work better.

The men taking part in this trial have prostate cancer that scans or blood tests show is getting worse. But their cancer is not causing symptoms or only causing very mild symptoms. The researchers will compare men in 3 groups

  • PROSTVAC alongside GM-CSF
  • PROSTVAC alongside a dummy drug
  • PROSTVAC dummy drug alongside GM-CSF dummy drug

The aims of the trial are to

You May Like: How Do I Know If I Have A Prostate Infection

Are There Vaccines That Treat Cancer

There are vaccines that treat existing cancer, called treatment vaccines or therapeutic vaccines. These vaccines are a type of cancer treatment called immunotherapy. They work to boost the body’s immune system to fight cancer. Doctors give treatment vaccines to people who already have cancer. Different treatment vaccines work in different ways. They can:

  • Keep the cancer from coming back

  • Destroy any cancer cells still in the body after treatments end

  • Stop a tumor from growing or spreading

Phases I And Ii Clinical Trials

Burch and colleagues at the Mayo Clinic conducted the first Phase I clinical trial of sipuleucel-T in 1997. The trial enrolled 13 patients with metastatic CRPC, treated with two infusions of sipuleucel-T one month apart, followed by 3 monthly subcutaneous injections of PA2024 alone at one of three dosage levels . At the end of the study, all patients evaluated for immune response developed antigen-specific T-cells. A drop in serum PSA level of 50% or more was

Recommended Reading: Nerve Regeneration After Prostate Surgery

Pancreatic Cancer Vaccine: What To Know About Early Promising Results

A personalised mRNA vaccine for pancreatic cancer has produced promising results in a small initial trial involving people whose cancers were detected early enough to be operated on

New mRNA vaccines for pancreatic cancer have shown promising results

Pancreatic cancer is the deadliest of cancers, with few treatment options. Now, an mRNA vaccine treatment, called autogene cevumeran, that is tailored to each individuals cancer has produced promising results in a small initial trial.

Future Of Health: Cancer Vaccines

New Vaccine Could Delay ADT Use in Stage D0 Prostate Cancer

When people consider vaccines, many think about the pandemic and about preventing illness. However, certain UW researchers have a very different focus when they work with vaccines.

For Dr. Douglas McNeel, professor of medicine at the UW School of Medicine and Public Health and genitourinary medical oncologist, UW Health, its about the future of specialized prostate cancer therapeutics.

Media inquiries

Our team is researching vaccines that could elicit prostate cancer-destructive immune responses, McNeel said. This kind of immuno-based therapy, by activating immune cells that are specific for the tumor, may be foundational to the future of cancer treatments.

Immunotherapy, a type of cancer treatment that helps ones immune system fight cancer, is still relatively new. According to McNeel, who is also director of solid tumor immunology research at the UW Carbone Cancer Center, as recently as 10 years ago there were only a handful of immunotherapies available. Today, upwards of 30% of patients with cancer receive some type of immunotherapy as part of their treatment plan, he said.

Its a very appealing option for patients and physicians, using a persons unique immune system to overcome cancer cells or shrink tumors, McNeel said. In many cases these treatments can be less invasive or taxing than more traditional methods like chemotherapies.


Read Also: What Not To Eat For Enlarged Prostate

Should I Have The Covid

This is a personal decision, and only you can decide whether to have the vaccine. But it is the best way to protect yourself against severe COVID-19 illness.

There is a lot of information on the internet about vaccines and its hard to know which information to trust. You can find the most up-to-date information about COVID-19 vaccines on the NHS website.

It may help to talk to your family or friends if youre not sure what to do. Your doctor or nurse can also talk to you about the vaccine and help you decide whats right for you.

Immunotherapy For Prostate Cancer

Surgery and radiation treat prostate cancer by removing or killing cancer cells. Immunotherapy is different. It trains your immune system to attack the cancer.

Cancer vaccines and checkpoint inhibitors are approved immunotherapies for prostate cancer. CAR T-cell therapy is a new treatment that doctors are learning more about in clinical trials.

You might be a good candidate for one of these treatments if your cancer didn’t stop growing or it came back after surgery or hormone therapy. Immunotherapy could help some people with prostate cancer live longer, but it does have some risks to discuss with your doctor.

You May Like: After Prostate Removal What To Expect

The Cancer Vaccine That Could Prevent Prostate Cancer

Harnessing the immune system could offer an entirely new way to stop prostate cancer, and our research is creating the technology to do it.

Vaccines everyones talking about them, but did you know its not just viruses that we can vaccinate against? Were supporting researchers who are developing a vaccine for prostate cancer that could treat men with prostate cancer and even prevent them getting the disease in the first place.

Please note this research project is still in the early stages. We hope the vaccine reaches clinical trials and if so, we’ll let our supporters know right away.

How The Vaccine Works

Immunotherapy in 2022: Provenge, Keytruda, Car-T, and Leukine for Prostate Cancer | Mark Scholz, MD

This vaccine has to be made especially for each man who gets it. Immune cells are taken from the man’s blood and sent to a lab. These immune cells are then exposed to a protein found on prostate cancer cells. At the same time, they are exposed to a chemical to boost the immune response. This helps the immune cells recognize and attack prostate cancer cells. They are then put back into the mans body, such as into a vein. Once back in the body, these cells help other immune cells attack the prostate cancer.

Also Check: Dog Prostate Cancer End Stage

The Above Policy Is Based On The Following References:

  • Adams E. Bibliography: Treatments for metastatic castrate-resistant prostate cancer. Boston, MA: VA Technology Assessment Program July 2010.
  • Amato RJ, Stepankiw M. Evaluation of MVA-5T4 as a novel immunotherapeutic vaccine in colorectal, renal and prostate cancer. Future Oncol. 2012 8:231-237.
  • Antonarakis ES, Drake CG. Current status of immunological therapies for prostate cancer. Curr Opin Urol. 2010 20:241-246.
  • BlueCross BlueShield Association , Technology Evaluation Center . Special report: Vaccines for the treatment of prostate cancer. TEC Assessment Program. Chicago, IL: BCBSA April 2010 24.
  • Bubley GJ, Carducci M, Dahut W, et al. Eligibility and response guidelines for phase II clinical trials in androgen independent prostate cancer: Recommendations from the Prostate-Specific Antigen Working Group. J Clin Oncol. 1999 17:3461-3467.
  • Canadian Coordinating Office for Health Technology Assessment . Vaccines for metastatic hormone-refractory prostate cancer. Emerging Drug List No. 66. Ottawa, ON: CCOHTA December 2005.
  • Cattrini C, Dellepiane C, Cavo A, et al. Immunotherapy for genitourinary cancer: State of the art and new perspectives. Anticancer Drugs. 2016 27:585-599.
  • Clinical Pharmacology powered by ClinicalKey. Tampa, FL: Elsevier, updated periodically. Available at: Accessed July 12, 2021.
  • Dendreon Corporation. Provenge suspension for intravenous infusion. Prescribing Information. Seattle, WA: Dendreon Corporation 2010.
  • Ive Already Had A Flu Jab Do I Still Need The Covid

    The flu jab doesnt protect against coronavirus. To protect yourself against the flu and coronavirus, you need to have both the flu vaccine and the COVID-19 vaccine.

    You wont be able to have the flu and COVID-19 vaccines at the same appointment youll need to leave at least a week in-between, to ensure they both work properly.

    Don’t Miss: What Are The Chances Of Getting Prostate Cancer

    Do Cancer Vaccines Work

    There have been many clinical trials testing cancer vaccines. There is one cancer vaccine found to improve overall survival. Sipuleucel-T is approved for use in some men with metastatic prostate cancer. It starts an immune response to prostatic acid phosphatase , an antigen present on most prostate cancers. This vaccine is customized for each patient. It is not known exactly how sipuleucel-T works, but it is likely that the APCs that have taken up PAP-GM-CSF help your T cells to kill tumor cells that express PAP.

    Another viral therapy approved for use is called talimogene laherparepvec and it is used to treat melanoma that can’t be removed with surgery. The drug is a weakened form of Herpes Simplex Virus Type 1. The medication is injected directly into the melanoma tumor on the skin or in a lymph node. This makes the cancer cells burst and die.

    A viral therapy called Bacillus Calmette-Guerin is a weakened strain of Mycobacterium bovis. It works against cancer as a biologic response modifier. This means that it can trigger the immune system to attack tumors. BCG is thought to work by starting an immune response and causing inflammation of the bladder wall that destroys cancer cells within the bladder.

    What To Expect For Your Treatment

    mRNA research produced COVID

    This vaccine is given as a series of 3 treatments. There are about 2 weeks between each treatment. Before each treatment, an IV line is put into a vein in your arm. Blood from your vein goes into the IV line. The IV leads to a machine that removes immune cells from your blood. This is done over a few hours. The immune cells are then sent to a lab, where they are treated so they will attack prostate cancer cells. The cells are then sent back to your healthcare provider’s office or hospital a few days later. An IV line is put into your arm. The cells are put back into your blood. This is called an infusion. It takes about an hour.

    You May Like: What Is A Fusion Biopsy Of The Prostate


    Most Popular